XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Impact of adoption
Preferred Stock
Common Stock
Additional Paid-In Capital
Treasury Stock
Retained Earnings / (Accumulated Deficit)
Retained Earnings / (Accumulated Deficit)
Impact of adoption
Beginning balance at Dec. 31, 2019 $ 11,210              
Increase (Decrease) in Temporary Equity [Roll Forward]                
Net income / (loss) attributable to common stockholders (236)              
Ending balance at Mar. 31, 2020 10,974              
Balance (in shares) at Dec. 31, 2019     0 48,701,000   0    
Balance at Dec. 31, 2019 355,651 $ (816) $ 0 $ 487 $ 365,627 $ 0 $ (10,463) $ (816)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock issued in connection with equity-based plans (in shares)       107,000        
Common stock issued in connection with equity-based plans 1,365     $ 1 1,364      
Stock-based compensation expense $ 6,358       6,358      
Purchases of treasury stock (in shares) 147,153         147,000    
Purchases of treasury stock $ (5,149)         $ (5,149)    
Net income / (loss) attributable to common stockholders 8,807           8,807  
Balance (in shares) at Mar. 31, 2020     0 48,808,000   147,000    
Balance at Mar. 31, 2020 366,216   $ 0 $ 488 373,349 $ (5,149) (2,472)  
Increase (Decrease) in Temporary Equity [Roll Forward]                
Accretion adjustments of redeemable noncontrolling interest to redemption value 112              
Net income / (loss) attributable to common stockholders (370)              
Ending balance at Jun. 30, 2020 10,716              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock issued in connection with equity-based plans (in shares)       263,000        
Common stock issued in connection with equity-based plans 3,059     $ 3 3,056      
Stock-based compensation expense $ 7,095       7,095      
Purchases of treasury stock (in shares) 0              
Accretion adjustments of redeemable noncontrolling interest to redemption value $ (112)       (112)      
Net income / (loss) attributable to common stockholders 16,995           16,995  
Balance (in shares) at Jun. 30, 2020     0 49,071,000   147,000    
Balance at Jun. 30, 2020 393,253   $ 0 $ 491 383,388 $ (5,149) 14,523  
Beginning balance at Dec. 31, 2020 10,691              
Increase (Decrease) in Temporary Equity [Roll Forward]                
Accretion adjustments of redeemable noncontrolling interest to redemption value 473              
Net income / (loss) attributable to common stockholders (280)              
Ending balance at Mar. 31, 2021 10,884              
Balance (in shares) at Dec. 31, 2020     0 49,631,000   147,000    
Balance at Dec. 31, 2020 467,752   $ 0 $ 496 405,831 $ (5,149) 66,574  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock issued in connection with equity-based plans (in shares)       173,000        
Common stock issued in connection with equity-based plans 1,989     $ 2 1,987      
Stock-based compensation expense 7,888       7,888      
Equity component of convertible senior notes, net 56,515       56,515      
Accretion adjustments of redeemable noncontrolling interest to redemption value (473)       (473)      
Net income / (loss) attributable to common stockholders 14,830           14,830  
Balance (in shares) at Mar. 31, 2021     0 49,804,000   147,000    
Balance at Mar. 31, 2021 548,501   $ 0 $ 498 471,748 $ (5,149) 81,404  
Beginning balance at Dec. 31, 2020 10,691              
Ending balance at Jun. 30, 2021 11,372              
Balance (in shares) at Dec. 31, 2020     0 49,631,000   147,000    
Balance at Dec. 31, 2020 $ 467,752   $ 0 $ 496 405,831 $ (5,149) 66,574  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Purchases of treasury stock (in shares) 0              
Balance (in shares) at Jun. 30, 2021     0 50,041,000   147,000    
Balance at Jun. 30, 2021 $ 573,437   $ 0 $ 500 481,937 $ (5,149) 96,149  
Beginning balance at Mar. 31, 2021 10,884              
Increase (Decrease) in Temporary Equity [Roll Forward]                
Accretion adjustments of redeemable noncontrolling interest to redemption value 743              
Net income / (loss) attributable to common stockholders (255)              
Ending balance at Jun. 30, 2021 11,372              
Balance (in shares) at Mar. 31, 2021     0 49,804,000   147,000    
Balance at Mar. 31, 2021 548,501   $ 0 $ 498 471,748 $ (5,149) 81,404  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock issued in connection with equity-based plans (in shares)       237,000        
Common stock issued in connection with equity-based plans 878     $ 2 876      
Stock-based compensation expense $ 10,056       10,056      
Purchases of treasury stock (in shares) 0              
Accretion adjustments of redeemable noncontrolling interest to redemption value $ (743)       (743)      
Net income / (loss) attributable to common stockholders 14,745           14,745  
Balance (in shares) at Jun. 30, 2021     0 50,041,000   147,000    
Balance at Jun. 30, 2021 $ 573,437   $ 0 $ 500 $ 481,937 $ (5,149) $ 96,149